SE436278B - CYCLOPENTAND DERIVATIVES FOR USE AS INTERMEDIATE IN THE PREPARATION OF PROSTAGLAND COMPOUNDS - Google Patents
CYCLOPENTAND DERIVATIVES FOR USE AS INTERMEDIATE IN THE PREPARATION OF PROSTAGLAND COMPOUNDSInfo
- Publication number
- SE436278B SE436278B SE7700717A SE7700717A SE436278B SE 436278 B SE436278 B SE 436278B SE 7700717 A SE7700717 A SE 7700717A SE 7700717 A SE7700717 A SE 7700717A SE 436278 B SE436278 B SE 436278B
- Authority
- SE
- Sweden
- Prior art keywords
- cyclopentand
- prostagland
- derivatives
- compounds
- preparation
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30481372A | 1972-11-08 | 1972-11-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7700717L SE7700717L (en) | 1977-01-24 |
| SE436278B true SE436278B (en) | 1984-11-26 |
Family
ID=23178133
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7314686A SE448992B (en) | 1972-11-08 | 1973-10-29 | PROCEDURE FOR PREPARING AN OMEGA-PENTANOR PROSTAGLANDIN FROM THE E OR F SERIES |
| SE7700717A SE436278B (en) | 1972-11-08 | 1977-01-24 | CYCLOPENTAND DERIVATIVES FOR USE AS INTERMEDIATE IN THE PREPARATION OF PROSTAGLAND COMPOUNDS |
| SE7700716A SE445111B (en) | 1972-11-08 | 1977-01-24 | SUBSTITUTED OMEGA-PENTANORPROSTAGLANDIN FROM E OR F SERIES FOR USE AS ANTIFERTILITY AGENT |
| SE7700718A SE431756B (en) | 1972-11-08 | 1977-01-24 | PHENOXI-2-OXOPROPYLPHOSPHONATE FOR USE AS INTERMEDIATE IN THE PREPARATION OF NEW W-PENTANORPROSTAGLANDINES |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7314686A SE448992B (en) | 1972-11-08 | 1973-10-29 | PROCEDURE FOR PREPARING AN OMEGA-PENTANOR PROSTAGLANDIN FROM THE E OR F SERIES |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7700716A SE445111B (en) | 1972-11-08 | 1977-01-24 | SUBSTITUTED OMEGA-PENTANORPROSTAGLANDIN FROM E OR F SERIES FOR USE AS ANTIFERTILITY AGENT |
| SE7700718A SE431756B (en) | 1972-11-08 | 1977-01-24 | PHENOXI-2-OXOPROPYLPHOSPHONATE FOR USE AS INTERMEDIATE IN THE PREPARATION OF NEW W-PENTANORPROSTAGLANDINES |
Country Status (29)
| Country | Link |
|---|---|
| JP (3) | JPS5416491B2 (en) |
| AR (3) | AR200585A1 (en) |
| AT (3) | AT367034B (en) |
| AU (1) | AU470375B2 (en) |
| BE (1) | BE806995A (en) |
| CA (3) | CA1085831A (en) |
| CH (1) | CH597176A5 (en) |
| CS (3) | CS182793B2 (en) |
| DD (4) | DD118856A5 (en) |
| DE (1) | DE2355540C2 (en) |
| DK (1) | DK144247C (en) |
| ES (3) | ES420325A1 (en) |
| FI (1) | FI60389C (en) |
| FR (3) | FR2205335B1 (en) |
| GB (3) | GB1456514A (en) |
| HK (3) | HK28079A (en) |
| HU (3) | HU173507B (en) |
| IE (1) | IE39537B1 (en) |
| IL (1) | IL43589A (en) |
| IN (1) | IN139384B (en) |
| KE (3) | KE2930A (en) |
| MY (3) | MY7900243A (en) |
| NL (1) | NL164273C (en) |
| NO (3) | NO147836C (en) |
| PH (3) | PH13272A (en) |
| SE (4) | SE448992B (en) |
| SU (4) | SU584766A3 (en) |
| YU (3) | YU39715B (en) |
| ZA (1) | ZA738554B (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3929862A (en) * | 1974-01-08 | 1975-12-30 | Upjohn Co | Substituted tolylesters of PGF{HD 2{B {60 |
| US3986764A (en) * | 1975-03-31 | 1976-10-19 | Gte Automatic Electric Laboratories Incorporated | Panel for supporting a pair of elongated mating connectors and selectively locking them together |
| GB1506817A (en) * | 1975-03-31 | 1978-04-12 | Upjohn Co | Prostaglandins |
| ES449162A1 (en) * | 1975-06-23 | 1977-12-16 | Syntex Inc | 16-Phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives |
| GB1516414A (en) * | 1975-08-22 | 1978-07-05 | Ici Ltd | Prostane derivatives |
| SE7809008L (en) * | 1977-12-12 | 1979-06-13 | Upjohn Co | USE OF PROSTAGLAND TYPE AMIDES TO CONTROL OR REGULATE THE REPRODUCTION CYCLE IN INDIVIDUALS OF MAMMALS |
| IN150279B (en) * | 1978-01-16 | 1982-09-04 | Pfizer | |
| EP1012137B1 (en) * | 1997-09-09 | 2002-11-06 | The Procter & Gamble Company | Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| NZ513825A (en) | 1999-03-05 | 2001-09-28 | Procter & Gamble | C 16 unsaturated FP-selective prostaglandins analogs |
| US6894175B1 (en) | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| JP2002329615A (en) * | 2001-05-02 | 2002-11-15 | Ohira Denshi Kk | Toroidal coil |
| US6476064B1 (en) * | 2001-06-13 | 2002-11-05 | Allergan, Inc. | Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents |
| JP2008517941A (en) | 2004-10-21 | 2008-05-29 | デューク・ユニバーシティー | Ophthalmic drugs |
| US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| US8623918B2 (en) | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1324737A (en) * | 1970-11-02 | 1973-07-25 | Upjohn Co | Prostaglandins and the preparation thereof |
| IE37602B1 (en) * | 1971-05-11 | 1977-08-31 | Ici Ltd | Cyclopentane derivatives |
-
1972
- 1972-11-07 DD DD182498*A patent/DD118856A5/xx unknown
-
1973
- 1973-10-29 SE SE7314686A patent/SE448992B/en unknown
- 1973-11-07 FI FI3443/73A patent/FI60389C/en active
- 1973-11-07 YU YU2880/73A patent/YU39715B/en unknown
- 1973-11-07 CA CA185,274A patent/CA1085831A/en not_active Expired
- 1973-11-07 CH CH1563973A patent/CH597176A5/xx not_active IP Right Cessation
- 1973-11-07 DD DD182497*A patent/DD117233A5/xx unknown
- 1973-11-07 IN IN2448/CAL/73A patent/IN139384B/en unknown
- 1973-11-07 DE DE2355540A patent/DE2355540C2/en not_active Expired
- 1973-11-07 ES ES420325A patent/ES420325A1/en not_active Expired
- 1973-11-07 DD DD174504A patent/DD109212A5/xx unknown
- 1973-11-07 AU AU62247/73A patent/AU470375B2/en not_active Expired
- 1973-11-07 JP JP12527273A patent/JPS5416491B2/ja not_active Expired
- 1973-11-07 GB GB2285876A patent/GB1456514A/en not_active Expired
- 1973-11-07 IE IE2002/73A patent/IE39537B1/en unknown
- 1973-11-07 PH PH15191A patent/PH13272A/en unknown
- 1973-11-07 NO NO4288/73A patent/NO147836C/en unknown
- 1973-11-07 AR AR250885A patent/AR200585A1/en active
- 1973-11-07 GB GB5175873A patent/GB1456512A/en not_active Expired
- 1973-11-07 DK DK601073A patent/DK144247C/en not_active IP Right Cessation
- 1973-11-07 ZA ZA738554A patent/ZA738554B/en unknown
- 1973-11-07 IL IL43589A patent/IL43589A/en unknown
- 1973-11-07 NL NL7315263.A patent/NL164273C/en not_active IP Right Cessation
- 1973-11-07 BE BE1005485A patent/BE806995A/en not_active IP Right Cessation
- 1973-11-07 AT AT0936973A patent/AT367034B/en not_active IP Right Cessation
- 1973-11-07 FR FR7339544A patent/FR2205335B1/fr not_active Expired
- 1973-11-07 GB GB2395076A patent/GB1456513A/en not_active Expired
- 1973-11-07 DD DD182499*A patent/DD119411A5/xx unknown
- 1973-11-08 CS CS7500006065A patent/CS182793B2/en unknown
- 1973-11-08 HU HU73PI451A patent/HU173507B/en unknown
- 1973-11-08 CS CS7300007669A patent/CS182791B2/en unknown
- 1973-11-08 CS CS7500006066A patent/CS182794B2/en unknown
- 1973-11-08 HU HU73PI00000452A patent/HU171819B/en unknown
- 1973-11-08 HU HU72PI00000399A patent/HU172703B/en unknown
- 1973-11-11 SU SU7301971722A patent/SU584766A3/en active
-
1974
- 1974-06-06 AR AR254091A patent/AR199966A1/en active
- 1974-06-06 AR AR254090A patent/AR202931A1/en active
- 1974-09-26 NO NO743493A patent/NO148998C/en unknown
- 1974-12-18 ES ES433046A patent/ES433046A1/en not_active Expired
- 1974-12-18 ES ES433047A patent/ES433047A1/en not_active Expired
-
1975
- 1975-02-18 SU SU752106791A patent/SU667141A3/en active
- 1975-02-18 NO NO750535A patent/NO149139C/en unknown
- 1975-02-19 SU SU752106125A patent/SU893130A3/en active
- 1975-07-24 PH PH17409A patent/PH13325A/en unknown
- 1975-07-24 PH PH17410A patent/PH13110A/en unknown
- 1975-08-22 FR FR7526059A patent/FR2279729A1/en active Granted
- 1975-08-22 FR FR7526060A patent/FR2283146A1/en active Granted
-
1976
- 1976-07-23 AT AT544676A patent/AT353285B/en active
- 1976-07-23 AT AT544576A patent/AT360672B/en not_active IP Right Cessation
- 1976-10-15 JP JP51123737A patent/JPS5253841A/en active Pending
- 1976-10-15 JP JP51123738A patent/JPS5257147A/en active Pending
-
1977
- 1977-01-24 SE SE7700717A patent/SE436278B/en not_active IP Right Cessation
- 1977-01-24 SE SE7700716A patent/SE445111B/en not_active IP Right Cessation
- 1977-01-24 SE SE7700718A patent/SE431756B/en not_active IP Right Cessation
- 1977-07-11 CA CA341,898A patent/CA1088931A/en not_active Expired
- 1977-07-11 CA CA341,897A patent/CA1088930A/en not_active Expired
-
1978
- 1978-07-27 SU SU782629453A patent/SU745362A3/en active
-
1979
- 1979-03-15 KE KE2930A patent/KE2930A/en unknown
- 1979-03-15 KE KE2932A patent/KE2932A/en unknown
- 1979-03-15 KE KE2931A patent/KE2931A/en unknown
- 1979-05-03 HK HK280/79A patent/HK28079A/en unknown
- 1979-05-03 HK HK279/79A patent/HK27979A/en unknown
- 1979-05-03 HK HK281/79A patent/HK28179A/en unknown
- 1979-12-30 MY MY243/79A patent/MY7900243A/en unknown
- 1979-12-30 MY MY246/79A patent/MY7900246A/en unknown
- 1979-12-30 MY MY245/79A patent/MY7900245A/en unknown
-
1980
- 1980-10-23 YU YU2707/80A patent/YU36975B/en unknown
- 1980-10-23 YU YU2706/80A patent/YU37316B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE405251B (en) | INTERMEDIATE ASSOCIATION FOR USE IN THE PREPARATION OF ANTIBIOTICALLY ACTIVE CEPHALOSPORINE COMPOUNDS | |
| SE436278B (en) | CYCLOPENTAND DERIVATIVES FOR USE AS INTERMEDIATE IN THE PREPARATION OF PROSTAGLAND COMPOUNDS | |
| SE385885B (en) | PROCEDURE FOR THE PREPARATION OF 4-AMINO-6-ARYLPYRIMIDINE DERIVATIVES | |
| SE403106B (en) | PROCEDURE FOR THE PREPARATION OF 14-HYDROXIMORPHININE DERIVATIVES | |
| SE395149B (en) | PROCEDURE FOR THE PREPARATION OF DIBENSO-TIEPINYLPIPERAZINE DERIVATIVES | |
| SE401676B (en) | PROCEDURE FOR THE PREPARATION OF DIBENSOFURAN DERIVATIVES | |
| SE386892B (en) | PROCEDURE FOR THE PREPARATION OF OXAMINO COMPOUNDS | |
| SE420604B (en) | PROCEDURE FOR THE PREPARATION OF OXAZOLD DERIVATIVES | |
| SE7712151L (en) | PROCEDURE FOR THE PREPARATION OF LINKOMYCIN DERIVATIVES | |
| SE423098B (en) | ASSOCIATION FOR USE IN THE PREPARATION OF CEPHALOSPORANIC ACID COMPOUNDS | |
| SE7511680L (en) | PROCEDURE FOR THE PREPARATION OF FURANDE DERIVATIVES | |
| SE399708B (en) | PROCEDURE FOR THE PREPARATION OF THIOXANTONE-2-CARBOXYLIC ACID DERIVATIVES | |
| SE416176B (en) | PROCEDURE FOR THE PREPARATION OF HIGH-DOSED AUTIBIOTIC TABLES | |
| SE380273B (en) | PROCEDURE FOR THE PREPARATION OF THIOPYRIMIDINE DERIVATIVES | |
| SE410459B (en) | INTERMEDIATE USE FOR THE PREPARATION OF A D-2-SUBSTITUTED-6-METHYL-8-SUBSTITUTED ERGOLINE | |
| SE384685B (en) | PROCEDURE FOR THE PREPARATION OF LINKOMYCIN DERIVATIVES | |
| SE7613500L (en) | PROCEDURE FOR THE PREPARATION OF CEFEM DERIVATIVES | |
| FI54023B (en) | ANORDNING VID ELDSTAEDER UPPBYGGDA AV S K MEMBRANVAEGGAR | |
| SE415659B (en) | PROCEDURE FOR THE PREPARATION OF BASIC SUBSTITUTED XANTEN AND TIOXANTEN DERIVATIVES | |
| SE402525B (en) | Process for the preparation of short-dissolution tablets containing allopurinol | |
| SE7602150L (en) | INTERMEDIATE PRODUCTS FOR THE PREPARATION OF 4A-ARYL-TRANS-DEKAHYDROISOKINOLINE | |
| SE403112B (en) | ANALOGICAL PROCEDURE FOR THE PREPARATION OF SKOPOLAMIN DERIVATIVES | |
| SE425786B (en) | INTERMEDIATE FOR THE PREPARATION OF ALKYLPHENYL BENZOPYRANOPYRIDINES | |
| SE409325B (en) | PROCEDURE FOR THE PREPARATION OF CHINAZOLINE DERIVATIVES | |
| DD106186A5 (en) | PREPARATION OF CEPHALOSPORIN DERIVATIVES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7700717-7 Effective date: 19930510 Format of ref document f/p: F |